Titan Pharmaceuticals Inc
TTNPDelisted Oct 2, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000910267
Titan Pharmaceuticals Inc was delisted on Oct 2, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 18 institutions reported holding it in 13F filings for Q3 2025, worth $107.1K in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Titan Pharmaceuticals Inc changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 23 | 22 | −1 |
| Shares | 581.2K | 386.9K | −194.3K (−33.4%) |
| Value | $1.51M | $722.0K | −$789.0K (−52.2%) |
New holders (3)
Institutions that held Titan Pharmaceuticals Inc at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 13,000 | $24.0K | 0.00% |
| Trust Co | 1 | $1.00K | 0.00% |
| Benjamin Edwards Inc | 2 | $0 | 0.00% |
Sold out (4)
Institutions that held Titan Pharmaceuticals Inc at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Citadel Advisors LLC | 68,908 | $179.0K |
| Virtu Financial LLC | 33,309 | $87.0K |
| Bank of New York Mellon Corp | 15,397 | $40.0K |
| Advisory Services Network, LLC | 9,000 | $23.0K |